RAJARAM, S.; MURUGAN, A.; C.M, N. Effect of Ascorbic Acid on dissolution stability of Rifampicin in market fixed dose combination products for Tuberculosis. PharmaTutor, v. 5, n. 1, p. 48-53, 1 jan. 2017.